Ambien Generics Grab 5 Percent of Insomnia Market In First Week
This article was originally published in The Pink Sheet Daily
Executive Summary
Zolpidem generics launched April 23 with 13 ANDA approvals.
You may also be interested in...
Orexo Files NDA For Dissolving Zolpidem
Payers likely to favor generic Ambien for short-term insomnia, analyst tells “The Pink Sheet” DAILY.
Orexo Files NDA For Dissolving Zolpidem
Payers likely to favor generic Ambien for short-term insomnia, analyst tells “The Pink Sheet” DAILY.
Neurocrine Resubmits Immediate-Release Indiplon
Sleep aid could at last reach market late in 2008.